Cite
HARVARD Citation
Rizos, C. et al. (2021). Implication of ESC/EAS 2019 dyslipidemia guidelines for PCSK9 inhibition in patients with familial hypercholesterolemia: An analysis from the Hellas-FH registry. Atherosclerosis. pp. e51-. [Online].